Telix: A masterclass in what this game is all about

Today's market darling reminds us why we love to invest. But is it too late?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Every now and again, an ASX company emerges that captures the hearts and minds of investors. 

It doesn't happen every year, but it certainly happens more often than you think. 

From Droneshield (ASX: DRO) to ProMedicus (ASX: PME) to Supply Network (ASX: SNL), these companies have all produced total returns in excess of 700% over the last 5 years. 

The latest market darling is, of course, none other than Telix Pharmaceuticals (ASX: TLX). 

Just 5 years ago, the company reported revenue of $3.5m and now its 2025 sales guidance is in excess of $1.2 billion (US$785m at the midpoint), a phenomenal 343x increase! 

Its share price has done alright, just a lazy 25x increase over the same period. 

It's the stuff that dreams are made of, and it reminds us why we love this game of investing. 

Now, if you cut out the hype, there are actually important investing lessons to learn from Telix.

A boy is excited because he won the computer game.

Image source: Getty Images

Stay optimistic and always look forward 

Five years ago, we were in the midst of a pandemic, and the world was facing a lot of uncertainty. (Not much has changed!). 

It would have been easy to ignore a small, speculative pharmaceutical company with $3.5m in revenue, but investing is all about looking ahead, imagining all the different possibilities, and pricing them accordingly. 

No matter what the headlines say, the share market will surprise you with the opportunities that it can create. Stay optimistic, always look forward. 

Business fundamentals matter

A 25x share price return is nice, but the real story here is the 343x increase in sales. Students of the game know how important it is to study the business and its fundamentals. 

The context matters too. Sales growth may be important for Telix now as a growth company, but perhaps at some point in the future, earnings per share and free cash flow will become more important metrics. 

Tough times will come 

Sorry to be the bearer of bad news, but tough times will eventually come. At some point, Telix shareholders will have to deal with a major share price decline. It could be up to a 20% decline, or it could be a lot more. 

It happens to every market darling, and it's just the nature of the beast. 

The time to mentally prepare yourself and work out what you would do in such a scenario is now. Write down your game plan, explain your rationale, and constantly re-evaluate it using the business fundamentals as your guide. Tough times will eventually come. 

You don't need a Telix to do well

Telix's monster returns are worth celebrating; this is a company solving real-world problems after all. But let me be clear: you don't need Telix to do well in the share market. 

I say this because it's natural for investors who have missed out on Telix to have that fear of missing out (FOMO). If that's you, remember that there are plenty of opportunities out there. 

They won't all do as well as Telix, but even a 2x return in 5 years (just short of a 15% compounded annual growth rate) is a great return. 

Find the next Telix 

Finally, it's of no use to just look back at Telix's success without applying the lessons to help us find the next Telix. Ultimately, finding winning companies is what this game is all about. That's why we love it. 

If you need some help doing that, I know a band of merry Fools who just might be able to help…

Motley Fool contributor Kevin Gandiya has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Supply Network Ltd, and Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus, Supply Network Ltd, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rare green day for investors this Tuesday.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares
Broker Notes

3 ASX 200 shares at 52-week lows: Buy, hold, or sell?

These ASX 200 shares have experienced significant falls over the past 12 months. Is there value here?

Read more »

Percentage sign with a rising zig zaggy arrow representing rising interest rates.
Share Market News

ASX 200 resilient in face of latest RBA interest rate increase

ASX 200 investors had widely been expecting the RBA to increase interest rates again today.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Share Fallers

Why New Hope, Pepper Money, Pro Medicus, and Reece shares are falling today

These shares are having a tough time on Tuesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Challenger, Meeka Metals, Vulcan Energy, and West African Resources shares are rising today

These shares are having a good session on Tuesday. But why?

Read more »

Worried woman calculating domestic bills.
Financial Shares

Pepper Money shares plunge 10% after Challenger slashes takeover offer

The revised proposal comes just over a month after the original takeover approach sparked a strong rally in Pepper’s share…

Read more »

Shattered investor with head in hands, with ASX chart in the background.
Share Market News

Worst fortnight in 4 years: How the Iran war is affecting ASX shares

Since the war began, the ASX 200 has fallen 6.5%, and the ASX All Ords has dropped 6.65%.

Read more »